Literature DB >> 4679646

Attenuation and characterisation of Edmonston-Zagreb measles virus.

D Ikić, M Juzbasić, M Beck, A Hrabar, T Cimbur-Schreiber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4679646

Source DB:  PubMed          Journal:  Ann Immunol Hung        ISSN： 0570-1708


× No keyword cloud information.
  9 in total

1.  Analysis of the noncoding regions of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  Generation of measles virus defective interfering particles and their presence in a preparation of attenuated live-virus vaccine.

Authors:  P Calain; L Roux
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

4.  Strain-specific differences in LFA-1 induction on measles virus-infected monocytes and adhesion and viral transmission to endothelial cells.

Authors:  K B Hummel; W J Bellini; M K Offermann
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates.

Authors:  Diane L Bolton; Sampa Santra; Cindy Swett-Tapia; Jerome Custers; Kaimei Song; Harikrishnan Balachandran; Linh Mach; Hussein Naim; Pamela A Kozlowski; Michelle Lifton; Jaap Goudsmit; Norman Letvin; Mario Roederer; Katarina Radošević
Journal:  Vaccine       Date:  2012-06-22       Impact factor: 3.641

6.  Exploratory re-encoding of yellow fever virus genome: new insights for the design of live-attenuated viruses.

Authors:  R Klitting; T Riziki; G Moureau; G Piorkowski; E A Gould; X de Lamballerie
Journal:  Virus Evol       Date:  2018-07-23

7.  Adaptation to cell culture induces functional differences in measles virus proteins.

Authors:  Bettina Bankamp; Judith M Fontana; William J Bellini; Paul A Rota
Journal:  Virol J       Date:  2008-10-27       Impact factor: 4.099

Review 8.  Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination.

Authors:  Aline Baldo; Evanthia Galanis; Frédéric Tangy; Philippe Herman
Journal:  Hum Vaccin Immunother       Date:  2015-12-02       Impact factor: 3.452

Review 9.  The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses-Not Just Another Brick in the Viral Nucleocapsid.

Authors:  Maja Šantak; Zrinka Matić
Journal:  Viruses       Date:  2022-03-03       Impact factor: 5.048
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.